Proton-pump inhibitor therapy and small bowel bacterial contamination

Proton Pump Inhibitor Therapy Use Does Not Predispose to Small Intestinal Bacterial Overgrowth

(2012) Shiva K Ratuapli et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Small Intestinal Bacterial Overgrowth in Patients With Lower Gastrointestinal Symptoms and a History of Previous Abdominal Surgery

(2011) Patrizio Petrone   ARCHIVES OF SURGERY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy

(2010) Lucio Lombardo et al.   Clinical Gastroenterology and Hepatology

Adverse effects of proton pump inhibitor drugs: clues and conclusions

(2010) Denis M McCarthy   CURRENT OPINION IN GASTROENTEROLOGY

Effects of long-term PPI treatment on producing bowel symptoms and SIBO

(2010) Debora Compare et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Small intestinal bacterial overgrowth syndrome

(2010) Jan Bures   WORLD JOURNAL OF GASTROENTEROLOGY

Methodology and Indications of H2-Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference

(2009)   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease

(2009) Jochen Klaus et al.   BMC GASTROENTEROLOGY

Review of rifaximin as treatment for SIBO and IBS

(2009) Mark Pimentel   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors?

(2008) Brennan M.R. Spiegel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Small intestinal bacterial overgrowth

(2008) S. V. Rana et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY